These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 9119961

  • 1. Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis.
    Lehmann D, Karussis DM, Fluresco D, Mizrachi-Koll R, Ovadia H, Shezen E, Kalland T, Abramsky O.
    J Neuroimmunol; 1997 Apr; 74(1-2):102-10. PubMed ID: 9119961
    [Abstract] [Full Text] [Related]

  • 2. Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes.
    Karussis D, Abramsky O, Rosenthal Y, Mizrachi-Koll R, Ovadia H.
    Immunol Lett; 1999 Apr 15; 67(3):203-8. PubMed ID: 10369127
    [Abstract] [Full Text] [Related]

  • 3. Selective downregulation of Th1 response by Linomide reduces autoimmunity but increases susceptibility to viral infection in BALB/c and SJL mice.
    Erälinna JP, Röyttä M, Hukkanen V, Zinhu D, Salmi AA, Salonen R.
    J Neuroimmunol; 1998 Aug 01; 88(1-2):165-76. PubMed ID: 9688338
    [Abstract] [Full Text] [Related]

  • 4. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).
    Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Kalland T, Abramsky O.
    Proc Natl Acad Sci U S A; 1993 Jul 15; 90(14):6400-4. PubMed ID: 8341645
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.
    Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Ben-Nun A, Kalland T, Abramsky O.
    Ann Neurol; 1993 Nov 15; 34(5):654-60. PubMed ID: 8239559
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of autoimmune disease by the immunomodulator linomide correlates with the ability to activate macrophages.
    Dahlén E, Andersson M, Dawe K, Tellander AC, Brunmark C, Björk A, Hedlund G.
    Autoimmunity; 2000 Oct 15; 32(3):199-211. PubMed ID: 11092700
    [Abstract] [Full Text] [Related]

  • 7. Semliki Forest virus infection is enhanced in Th1-prone SJL mice but not in Th2-prone BALB/c mice during Linomide-induced immunomodulation.
    Peltoniemi J, Setälä N, Broberg E, Röyttä M, Hukkanen V, Salmi AA, Erälinna JP.
    J Neuroimmunol; 2002 Nov 15; 132(1-2):83-92. PubMed ID: 12417437
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti-inflammatory cytokines.
    Diab A, Michael L, Wahren B, Deng GM, Björk J, Hedlund G, Zhu J.
    J Neuroimmunol; 1998 May 15; 85(2):146-54. PubMed ID: 9630163
    [Abstract] [Full Text] [Related]

  • 11. Cytokine production in Linomide-treated nod mice and the potential role of a Th (1)/Th(2) shift on autoimmune and anti-inflammatory processes.
    Weiss L, Barak V, Zeira M, Abdul-Hai A, Raibstein I, Reich S, Hirschfeld E, Gross D, Slavin S.
    Cytokine; 2002 Jul 21; 19(2):85-93. PubMed ID: 12182843
    [Abstract] [Full Text] [Related]

  • 12. Effect of Linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
    Abdul-Hai A, Hershkoviz R, Weiss L, Lider O, Slavin S.
    Int Immunopharmacol; 2005 Feb 21; 5(2):231-9. PubMed ID: 15652754
    [Abstract] [Full Text] [Related]

  • 13. The inhibitory effect in experimental autoimmune encephalomyelitis by the immunomodulatory drug Linomide (PNU-212616) is not mediated via release of endogenous glucocorticoids.
    Pekarski O, Björk J, Hedlund G, Andersson G.
    Autoimmunity; 1998 Feb 21; 28(4):235-41. PubMed ID: 9892505
    [Abstract] [Full Text] [Related]

  • 14. Immunomodulation with linomide: possible novel therapy for multiple sclerosis.
    Abramsky O, Lehmann D, Karussis D.
    Mult Scler; 1996 Nov 21; 2(4):206-10. PubMed ID: 9345375
    [Abstract] [Full Text] [Related]

  • 15. Linomide-mediated protection of oligodendrocytes is associated with inhibition of nitric oxide production and IL-1beta expression in Lewis rat glial cells.
    Xiao BG, Bail XF, Zhang GX, Hedlund G, Link H.
    Neurosci Lett; 1998 Jun 12; 249(1):17-20. PubMed ID: 9672378
    [Abstract] [Full Text] [Related]

  • 16. Immunomodulation of experimental autoimmune myasthenia gravis with linomide.
    Karussis DM, Lehmann D, Brenner T, Wirguin I, Mizrachi-Koll R, Sicsic C, Abramsky O.
    J Neuroimmunol; 1994 Dec 12; 55(2):187-93. PubMed ID: 7829669
    [Abstract] [Full Text] [Related]

  • 17. Linomide activates the adrenocortical axis in the rat: inhibition of experimental autoimmune encephalomyelitis by linomide is not related to the increase of corticosterone.
    Weidenfeld J, Karussis D, Abramsky O, Lehmann D, Arbell I, Ovadia H.
    J Neuroimmunol; 1997 Oct 12; 79(1):49-53. PubMed ID: 9357446
    [Abstract] [Full Text] [Related]

  • 18. The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice.
    Morecki S, Nabet C, Falk P, Fridkis-Hareli M, Pecht I, Mond JJ, Slavin S.
    Autoimmunity; 1997 Oct 12; 25(4):223-32. PubMed ID: 9344330
    [Abstract] [Full Text] [Related]

  • 19. Linomide enhances apoptosis in CD4+CD8+ thymocytes.
    Harring AC, Xu Z, Andersson G, Hedlund G.
    Scand J Immunol; 1997 Nov 12; 46(5):488-94. PubMed ID: 9393631
    [Abstract] [Full Text] [Related]

  • 20. Immunomodulation of autoimmunity by linomide.
    Karussis DM, Lehmann D, Slavin S, Kalland T, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Abramsky O.
    Isr J Med Sci; 1995 Jan 12; 31(1):38-41. PubMed ID: 7836046
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.